Five years since buying Toll Holdings for $8 billion, Japan Post has kicked its exit plans up a gear.
Tonight, we provide a full update on the mooted sale process and reveal what the next item on Japan Post’s agenda is before it starts approaching suitors. It’s an important next step that has the potential to play a big role in the sale and we unpack why.
Meanwhile, local private equity firm Crescent Capital Partners has appointed an investment bank to sell its medical centres business, Myhealth Medical Group.
Nomura, having done the early work, is riding shotgun, while Japan Post has been interviewing accounting firms for the big role of vendor due diligence.